Table 4 CD34+ % & SDF-1 α mRNA expression and concentration gradient in the 5 study groups

CD34+ % in blood

(mean±SE)

8.98 ± 0.21

23.72 ± 0.23^ab

50.65 ± 0.44^a

4549.402

< 0.001

0.998

22.33831

CD34+ % in liver

(mean±SE)

3.1 ± 0.37

35.08 ± 0.41^ab

55.05 ± 0.23^a

9331.564

<0.001

0.999

31.60696

SDF-1 α mRNA gene expression in bone marrow

(mean±SE)

19.12 ± 0.19

8.62 ± 0.21^ab

2.36 ± 0.15^a

2044.276

<0.001

0.996

15.77973

SDF-1 α mRNA gene expression in liver

(mean±SE)

1.11 ± 0.004

13.0 ± 0.06^ab

19.33 ± 0.19^a

6433.868

<0.001

0.999

31.60696

SDF-1 α concentration gradient

(mean±SE)

-18 ± 0.19

4.38 ± 0.18^ab

17 ± 0.17^a

9480.891

<0.001

0.999

31.60696

2wks reversion

4wks reversion

F

p -value

Partial η2 (b)

Cohen’s f

CD34+ % in blood

(mean±SE)

37.5 ± 0.50^ab

26.37 ± 0.58^abc

1508.696

<0.001

0.996

15.77973

CD34+ %

in liver

(mean±SE)

42.8 ± 0.46^ab

34.57 ± 0.51^abc

3789.609

<0.001

0.998

22.33831

SDF-1 α mRNA gene expression in bone marrow

(mean±SE)

5.69 ± 0.16^ab

8.22 ± 0.26^abc

1394.804

<0.001

0.995

14.10674

SDF-1 α mRNA gene expression in liver

(mean±SE)

15.04 ± 0.02^ab

11.79 ± 0.34^abc

1560.472

<0.001

0.996

15.77973

SDF-1 α concentration gradient

(mean±SE)

9 ± 0.15^ab

4 ± 0.59^abc

2048.795

<0.001

0.997

18.23001